Latest Market Entry News

Sprintex has advanced a promising trial with a major Dutch agribusiness, potentially unlocking €4.8 million in sales, while also securing a significant private-label contract in China’s booming aquaculture sector.

Memphasys Limited has submitted its Felix™ sperm separation system for CE Mark approval, targeting Europe’s $5 billion IVF market, while expanding direct sales in Japan and validating its RoXsta™ oxidative stress diagnostic platform.

ReNerve Limited reported a robust 53% increase in annual revenue, driven by strategic partnerships and new regulatory approvals that broaden its global footprint in nerve repair.

Aurora Labs has advanced its micro gas turbine program with key test bench upgrades, a significant Defence grant, and strategic partnerships, positioning itself for international defence market entry.

Impact Minerals reports a robust Preliminary Feasibility Study for its Lake Hope High Purity Alumina project, underpinned by strong economics and low production costs, while strategically acquiring a 50% stake in Alluminous Pty Ltd to fast-track market entry with HiPurA® technology.

NGX Limited progresses its Malingunde graphite project with technical studies and stakeholder engagement, while uranium exploration permits advance in Namibia. The company stands to benefit from new US anti-dumping tariffs on Chinese graphite imports.

Felix Gold is advancing its Treasure Creek Project in Alaska, aiming for the first domestic antimony concentrate production in over 30 years by late 2025 or early 2026, supported by strong government engagement and solid finances.

HITIQ Ltd has launched its PROTEQT smart mouthguard for grassroots sports, secured a five-year exclusive global partnership with Shock Doctor, and raised $1.9 million to fund manufacturing and market growth.

Nanoveu Limited has accelerated its commercial and technological momentum with a $3.02 million capital raise, a breakthrough 33% increase in drone flight time using its edge-AI chip, and progress toward a U.S. OTCQB listing.

WhiteHawk Limited reported solid Q2 revenue growth with new US contracts and is advancing its Australian market entry, while managing cash flow challenges.

Industrial Minerals Ltd reports significant progress on its Pippingarra Project, advancing strategic partnerships across the Asia-Pacific and validating high purity quartz, feldspar, and mica products through positive testwork results.

LTR Pharma has initiated commercial distribution of its nasal spray SPONTAN through Australia's Symbion pharmacy network and is advancing ROXUS development for a US launch in early 2026, while expanding its pipeline with a new intranasal treatment for swallowing disorders.